80 related articles for article (PubMed ID: 19876383)
1. Surrogate indicators of sensitivity in gynecologic cytology: can they be used to improve the measurement of sensitivity in the laboratory?
Renshaw AA; Brimo F; Auger M
Cytojournal; 2009 Oct; 6():19. PubMed ID: 19876383
[TBL] [Abstract][Full Text] [Related]
2. ASC/SIL Ratio for Cytotechnologists: A surrogate marker of screening sensitivity.
Renshaw AA; Deschênes M; Auger M
Am J Clin Pathol; 2009 Jun; 131(6):776-81. PubMed ID: 19461082
[TBL] [Abstract][Full Text] [Related]
3. ASC/SIL ratio for cytotechnologists: A survey of its utility in clinical practice.
Renshaw AA; Auger M; Birdsong G; Cibas ES; Henry M; Hughes JH; Moriarty A; Tench W; Wilbur DC; Elsheikh TM
Diagn Cytopathol; 2010 Mar; 38(3):180-3. PubMed ID: 19760762
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of smear cytology & hybrid capture II for the diagnosis of cervical cancer.
Kumar K; Iyer VK; Bhatla N; Kriplani A; Verma K
Indian J Med Res; 2007 Jul; 126(1):39-44. PubMed ID: 17890822
[TBL] [Abstract][Full Text] [Related]
5. Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology.
Davey DD; Neal MH; Wilbur DC; Colgan TJ; Styer PE; Mody DR
Arch Pathol Lab Med; 2004 Nov; 128(11):1224-9. PubMed ID: 15504056
[TBL] [Abstract][Full Text] [Related]
6. Atypical squamous cells: update on current concepts.
Nayar R; Tabbara SO
Clin Lab Med; 2003 Sep; 23(3):605-32. PubMed ID: 14560531
[TBL] [Abstract][Full Text] [Related]
7. Rapid prescreen of cervical liquid-based cytology preparations: results of a study in an academic medical center.
Frable WJ; Pedigo MA; Powers CN; Yarrell C; Ortiz B; Clark ME; Ebron T
Diagn Cytopathol; 2012 Aug; 40(8):691-7. PubMed ID: 22807384
[TBL] [Abstract][Full Text] [Related]
8. Anal Cytology: Institutional Statistics, Correlation With Histology, and Development of Multidisciplinary Screening Program With Review of the Current Literature.
Morency EG; Harbert T; Fatima N; Samolcyzk J; Maniar KP; Nayar R
Arch Pathol Lab Med; 2019 Jan; 143(1):23-29. PubMed ID: 29652190
[TBL] [Abstract][Full Text] [Related]
9. Does the ThinPrep Imaging System increase the detection of high-risk HPV-positive ASC-US and AGUS? The Women and Infants Hospital experience with over 200,000 cervical cytology cases.
Quddus MR; Neves T; Reilly ME; Steinhoff MM; Sung CJ
Cytojournal; 2009 Aug; 6():15. PubMed ID: 19826482
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology.
Liu AH; Walker J; Gage JC; Gold MA; Zuna R; Dunn ST; Schiffman M; Wentzensen N
Obstet Gynecol; 2017 Dec; 130(6):1218-1225. PubMed ID: 29112672
[TBL] [Abstract][Full Text] [Related]
11. Squamous intraepithelial lesions (SIL: LSIL, HSIL, ASCUS, ASC-H, LSIL-H) of Uterine Cervix and Bethesda System.
Alrajjal A; Pansare V; Choudhury MSR; Khan MYA; Shidham VB
Cytojournal; 2021; 18():16. PubMed ID: 34345247
[TBL] [Abstract][Full Text] [Related]
12. Systemic cervical cytology training and quality control programs can improve the interpretation of Papanicolaou tests.
Xie F; Li Z; Zhang L; Zhang H; Qi D; Zhao D; Zhang X; Wang X; Zhao C
J Am Soc Cytopathol; 2019; 8(1):27-33. PubMed ID: 30929756
[TBL] [Abstract][Full Text] [Related]
13. Using the ASC:SIL ratio, human papillomavirus, and interobserver variability to assess and monitor cytopathology fellow training performance.
Chebib I; Rao RA; Wilbur DC; Tambouret RH
Cancer Cytopathol; 2013 Nov; 121(11):638-43. PubMed ID: 23861336
[TBL] [Abstract][Full Text] [Related]
14. Applicability of the Bethesda System 2001 to a public health setting.
Prandi S; Beccati D; De Aloysio G; Fulgenzi P; Gabrielli M; Ghirardini C; Rivasi F; Saragoni L; de Bianchi PS; Bucchi L
Cancer; 2006 Oct; 108(5):271-6. PubMed ID: 16948127
[TBL] [Abstract][Full Text] [Related]
15. Triaging Atypical Squamous Cells-Cannot Exclude High-Grade Squamous Intraepithelial Lesion With p16/Ki67 Dual Stain.
Šekoranja D; Repše Fokter A
J Low Genit Tract Dis; 2017 Apr; 21(2):108-111. PubMed ID: 28244884
[TBL] [Abstract][Full Text] [Related]
16. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
17. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
18. Measuring the significance of workload on performance of cytotechnologists in gynecologic cytology: a study using rapid prescreening.
Deschenes M; Renshaw AA; Auger M
Cancer; 2008 Jun; 114(3):149-54. PubMed ID: 18412150
[TBL] [Abstract][Full Text] [Related]
19. Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.
Yang J; Nolte FS; Chajewski OS; Lindsey KG; Houser PM; Pellicier J; Wang Q; Ehsani L
Diagn Cytopathol; 2018 Jan; 46(1):22-27. PubMed ID: 29048733
[TBL] [Abstract][Full Text] [Related]
20. Performance of rapid prescreening and 100% rapid review as internal quality control methods for cervical cytopathology.
Tobias AHG; Vitalino AC; Rezende MT; Oliveira RRR; Coura-Vital W; Amaral RG; Carneiro CM
Cytopathology; 2018 Oct; 29(5):428-435. PubMed ID: 29904955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
